Catalyst Wire Dossier Catalyst Wire Dossier

Celecoxib 200 mg bid

celecoxib · Pfizer / Upjohn (now Viatris via merger)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Celecoxib 200 mg bid, covering 2021-03-03 to 2021-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In Japan [Phase 3]

See pricing